Zhejiang Hisoar Pharmaceutical Co., Ltd.

¥5.76As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002099Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (4.17%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.34
PE TTM —
TSR TTM 0.35%
Mkt cap ¥8.872B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.93
20.29%
(55.79%)
Hold 10|12|6|0|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.17
0.17
25.04%
15.14%
14.09%
19.68%
Revenue¥M
486.9
494.4
507.2
503.3
(2.02%)
(2.80%)
2.41%
1.56%
Peers
Cap (US$)
PE
—
—
—
—
—
—
—
—
—
—
—
—
Capital
TTM
5Y
10Y
Leveragex
5.224
0.040
0.031
EBIT/Intx
3.830
0.212
0.212
Own earn%
102.65
44.30
56.47
Sh yield%
46.75
51.04
50.41
Owners
Insiders/Inst%
11.84
73.65
Short interest%
3.06
SBC / revenue%
3.87
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
3–12
$1 testx
0.0
Incr. ROIC%
26